Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models
- 1 August 1997
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1361 (2) , 203-216
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Enzyme replacement in a canine model of Hurler syndrome.Proceedings of the National Academy of Sciences, 1994
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblastsNature Genetics, 1993
- Long‐term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotypeJournal of Inherited Metabolic Disease, 1993
- Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transferNature, 1992
- Correction of Mucopolysaccharidosis Type I Fibroblasts by Retroviral-Mediated Transfer of the Human α- l -Iduronidase GeneHuman Gene Therapy, 1992
- Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher diseaseThe Journal of Pediatrics, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and CGenomics, 1990
- Immunoquantification of the low abundance lysosomal enzymeN‐acetylgalactosamine 4‐sulphataseJournal of Inherited Metabolic Disease, 1989